CIK 0001356090 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in VA · fiscal year ends 12/31
| FY2025 | FY2024 | FY2022 | FY2021 | |
|---|---|---|---|---|
| Revenue (USD) | 9.7 M | 26.9 M | ||
| Net income (USD) | -170.5 M | -322.3 M | ||
| Diluted EPS (USD/shares) | -1.37 | 0.14 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-09-24 | 4 | FORM 4 | 2026-09-23 |
| 2026-08-28 | 4 | FORM 4 | 2026-08-26 |
| 2026-08-26 | 144 | 144 | |
| 2026-08-25 | 4 | FORM 4 | 2026-08-21 |
| 2026-08-25 | 4 | FORM 4 | 2026-08-23 |
| 2026-08-25 | 4 | FORM 4 | 2026-08-23 |
| 2026-08-25 | 4 | FORM 4 | 2026-08-21 |
| 2026-08-25 | 4 | FORM 4 | 2026-08-23 |
| 2026-08-25 | 4 | FORM 4 | 2026-08-23 |
| 2026-08-25 | 144 | 144 | |
| 2026-08-25 | 144 | 144 | |
| 2026-08-21 | 144 | 144 | |
| 2026-08-07 | 4 | FORM 4 | 2026-08-06 |
| 2026-08-07 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-06 | 144 | 144 | |
| 2026-08-04 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-04 | 8-K | FORM 8-K items 2.02 | 2026-08-04 |
| 2026-08-03 | 4 | FORM 4 | 2026-08-03 |
| 2026-08-03 | 144 | 144 | |
| 2026-07-31 | 4 | FORM 4 | 2026-07-31 |
| 2026-07-31 | 144 | 144 | |
| 2026-07-01 | 4 | FORM 4 | 2026-06-29 |
| 2026-07-01 | 4 | FORM 4 | 2026-06-29 |
| 2026-07-01 | 4 | FORM 4 | 2026-06-29 |
| 2026-07-01 | 144 | 144 |
Forms on file (last 1,000): 4 629, 8-K 133, 10-Q 32, 144 21, SC 13D/A 17, 3 15, UPLOAD 14, 424B5 13. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=PGEN (0.002 USD), /gw/filings/filings?ticker=PGEN&form=8-K, /gw/filings/facts?ticker=PGEN&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange